The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration

eLife

Volumn 4, Issue NOVEMBER2015, 2015, Pages

  Hesse, Robert G ^a   Kouklis, Gayle K ^a   Ahituv, Nadav ^b   Pomerantz, Jason H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; PROTEIN P53; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN BINDING; TRANSCRIPTION FACTOR E2F;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION ASSAY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE CONTROL; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOLECULAR EVOLUTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ASSAY; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ZEBRA FISH; ANIMAL; METABOLISM; PROMOTER REGION; REGENERATION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; E2F TRANSCRIPTION FACTORS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REGENERATION; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; ZEBRAFISH;

EID: 84949958311     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.07702     Document Type: Article

References (60)

1. Belyi VA, Ak P, Markert E, Wang H, Hu W, Puzio-Kuter A, Levine AJ. 2010. The origins and evolution of the p53 family of genes. Cold Spring Harbor Perspectives in Biology 2:a001198. doi: 10.1101/cshperspect.a001198
2. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CDM, Morris JP, Liu TX, Schulte-Merker S, Kanki JP, Plasterk R, Zon LI, Look AT. 2005. Tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proceedings of the National Academy of Sciences of the United States of America 102:407–412. doi: 10.1073/pnas.0406252102
3. Berman SD, Yuan TL, Miller ES, Lee EY, Caron A, Lees JA. 2008. The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone development. Molecular Cancer Research : MCR 6:1440–1451. doi: 10.1158/1541-7786.MCR-08-0176
4. Brockes JP, Kumar A. 2008. Comparative aspects of animal regeneration. Annual Review of Cell and Developmental Biology 24:525–549. doi: 10.1146/annurev.cellbio.24.110707.175336
5. Chin L, Pomerantz J, DePinho RA. 1998. The INK4a/ARF tumor suppressor: one gene—two products—two pathways. Trends in Biochemical Sciences 23:291–296. doi: 10.1016/S0968-0004(98)01236-5
6. Chitramuthu BP, Bennett HPJ. 2013. High resolution whole mount in situ hybridization within zebrafish embryos to study gene expression and function. Journal of Visualized Experiments : JoVE:e50644. doi: 10.3791/50644
7. Clark LD, Clark RK, Heber-Katz E. 1998. A new murine model for mammalian wound repair and regeneration. Clinical Immunology and Immunopathology 88:35–45. doi: 10.1006/clin.1998.4519
8. Damalas A, Velimezi G, Kalaitzakis A, Liontos M, Papavassiliou AG, Gorgoulis V, Angelidis C. 2011. Loss of p14 (ARF) confers resistance to heat shock- and oxidative stress-mediated cell death by upregulating b-catenin. International Journal of Cancer. Journal International Du Cancer 128:1989–1995. doi: 10.1002/ijc.25510
9. Danilova N, Bibikova E, Covey TM, Nathanson D, Dimitrova E, Konto Y, Lindgren A, Glader B, Radu CG, Sakamoto KM, Lin S. 2014. The role of the DNA damage response in zebrafish and cellular models of diamond blackfan anemia. Disease Models & Mechanisms 7:895–905. doi: 10.1242/dmm.015495
10. del Arroyo AG, El Messaoudi S, Clark PA, James M, Stott F, Bracken A, Helin K, Peters G. 2007. E2F-dependent induction of p14ARF during cell cycle re-entry in human t cells. Cell Cycle (Georgetown, Tex.) 6:2697–2705. doi: 10.4161/cc.6.21.4857
11. Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Giron CG, Gordon L, Hourlier T, Hunt S, Johnson N, Juettemann T, Kahari AK, Keenan S, Kulesha E, Martin FJ, Maurel T, McLaren WM, Murphy DN, Nag R, Overduin B, Pignatelli M, Pritchard B, Pritchard E, Riat HS, Ruffier M, Sheppard D, Taylor K, Thormann A, Trevanion SJ, Vullo A, Wilder SP, Wilson M, Zadissa A, Aken BL, Birney E, Cunningham F, Harrow J, Herrero J, Hubbard TJP, Kinsella R, Muffato M, Parker A, Spudich G, Yates A, Zerbino DR, Searle SMJ. 2014. Ensembl 2014. Nucleic Acids Research 42:D749–D755. doi: 10.1093/nar/gkt1196
12. Gauron C, Rampon C, Bouzaffour M, Ipendey E, Teillon J, Volovitch M, Vriz S. 2013. Sustained production of ROS triggers compensatory proliferation and is required for regeneration to proceed. Scientific Reports 3 doi: 10.1038/srep02084
13. Gemberling M, Bailey TJ, Hyde DR, Poss KD. 2013. The zebrafish as a model for complex tissue regeneration. Trends in Genetics : TIG 29:611–620. doi: 10.1016/j.tig.2013.07.003
14. Gil J, Peters G. 2006. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nature Reviews. Molecular Cell Biology 7:667–677. doi: 10.1038/nrm1987
15. Gilley J, Fried M. 2001. One INK4 gene and no ARF at the fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Oncogene 20:7447–7452. doi: 10.1038/sj.onc.1204933
16. Greaves M. 2007. Darwinian medicine: a case for cancer. Nature Reviews. Cancer 7:213–221. doi: 10.1038/nrc2071
17. Gromley A, Churchman ML, Zindy F, Sherr CJ. 2009. Transient expression of the arf tumor suppressor during male germ cell and eye development in arf-cre reporter mice. Proceedings of the National Academy of Sciences of the United States of America 106:6285–6290. doi: 10.1073/pnas.0902310106
18. Halloran MC, Sato-Maeda M, Warren JT, Su F, Lele Z, Krone PH, Kuwada JY, Shoji W. 2000. Laser-induced gene expression in specific cells of transgenic zebrafish. Development (Cambridge, England) 127:1953–1960.
19. Heber-Katz E, Zhang Y, Bedelbaeva K, Song F, Chen X, Stocum DL. 2013. Cell cycle regulation and regeneration. Current Topics in Microbiology and Immunology 367:253–276. doi: 10.1007/82_2012_294
20. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992. Effects of an rb mutation in the mouse. Nature 359:295–300. doi: 10.1038/359295a0
21. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649–659. doi: 10.1016/S0092-8674(00)80452-3
22. Kim S-H, Mitchell M, Fujii H, Llanos S, Peters G. 2003. Absence of p16INK4a and truncation of ARF tumor suppressors in chickens. Proceedings of the National Academy of Sciences of the United States of America 100:211–216. doi: 10.1073/pnas.0135557100
23. Knopf F, Hammond C, Chekuru A, Kurth T, Hans S, Weber CW, Mahatma G, Fisher S, Brand M, Schulte-Merker S, Weidinger G. 2011. Bone regenerates via dedifferentiation of osteoblasts in the zebrafish fin. Developmental Cell 20:713–724. doi: 10.1016/j.devcel.2011.04.014
24. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. 1999. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285:1733–1737. doi: 10.1126/science.285.5434.1733
25. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien C-B. 2007. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Developmental Dynamics : An Official Publication of the American Association of Anatomists 236:3088–3099. doi: 10.1002/dvdy.21343
26. Lowe SW, Sherr CJ. 2003. Tumor suppression by Ink4a–arf: progress and puzzles. Current Opinion in Genetics & Development 13:77–83. doi: 10.1016/S0959-437X(02)00013-8
27. MacDonald R. 1999. Zebrafish Immunohistochemistry. In: Guille M. (ed.) Molecular Methods in Developmental Biology. Humana Press.
28. MacDonald RB, Debiais-Thibaud M, Talbot JC, Ekker M. 2010. The relationship between dlx and gad1 expression indicates highly conserved genetic pathways in the zebrafish forebrain. Developmental Dynamics 239:2298–2306. doi: 10.1002/dvdy.22365
29. Menéndez S, Khan Z, Coomber DW, Lane DP, Higgins M, Koufali MM, Lain S. 2003. Oligomerization of the human ARF tumor suppressor and its response to oxidative stress. The Journal of Biological Chemistry 278: 18720–18729. doi: 10.1074/jbc.M211007200
30. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. 2005. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes & Development 19:1432–1437. doi: 10.1101/gad.1299505
31. Monaghan JR, Maden M. 2013. Cellular plasticity during vertebrate appendage regeneration. Current Topics in Microbiology and Immunology 367:53–74. doi: 10.1007/82_2012_288
32. Morgan TH. 1901. Regeration and liability to injury. Science (New York, N.Y.) 14:235–248. doi: 10.1126/science.14.346.235
33. Muneoka K, Allan CH, Yang X, Lee J, Han M. 2008. Mammalian regeneration and regenerative medicine. Birth Defects Research. Part C, Embryo Today : Reviews 84:265–280. doi: 10.1002/bdrc.20137
34. Pajcini KV, Corbel SY, Sage J, Pomerantz JH, Blau HM. 2010. Transient inactivation of rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell 7:198–213. doi: 10.1016/j.stem.2010.05.022
35. Pardal R, Molofsky AV, He S, Morrison SJ. 2005. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harbor Symposia on Quantitative Biology 70:177–185. doi: 10.1101/sqb.2005.70.057
36. Pearson BJ, Sánchez Alvarado A. 2008. Regeneration, stem cells, and the evolution of tumor suppression. Cold Spring Harbor Symposia on Quantitative Biology 73:565–572. doi: 10.1101/sqb.2008.73.045
37. Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, Depinho RA. 1998. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 92:713–723. doi: 10.1016/S0092-8674(00)81400-2
38. Pomerantz JH, Blau HM. 2013. Tumor suppressors: enhancers or suppressors of regeneration? Development (Cambridge, England) 140:2502–2512. doi: 10.1242/dev.084210
39. Poss KD. 2010. Advances in understanding tissue regenerative capacity and mechanisms in animals. Nature Reviews. Genetics 11:710–722. doi: 10.1038/nrg2879
40. Poss KD, Keating MT, Nechiporuk A. 2003. Tales of regeneration in zebrafish. Developmental Dynamics : An Official Publication of the American Association of Anatomists 226:202–210. doi: 10.1002/dvdy.10220
41. Robertson KD, Jones PA. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Molecular and Cellular Biology 18: 6457–6473. doi: 10.1128/MCB.18.11.6457
42. Rodier F, Campisi J, Bhaumik D. 2007. Two faces of p53: aging and tumor suppression. Nucleic Acids Research 35:7475–7484. doi: 10.1093/nar/gkm744
43. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA, Serrano M. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27–37. doi: 10.1016/S0092-8674(00)81079-X
44. Sharpless NE. 2005. INK4a/ARF: a multifunctional tumor suppressor locus. Mutation Research 576:22–38. doi: 10.1016/j.mrfmmm.2004.08.021
45. Sharpless NE, Depinho RA. 2007. How stem cells age and why this makes us grow old. Nature Reviews. Molecular Cell Biology 8:703–713. doi: 10.1038/nrm2241
46. Sherr CJ. 2006. Divorcing ARF and p53: an unsettled case. Nature Reviews. Cancer 6:663–673. doi: 10.1038/nrc1954
47. Smith JJ, Putta S, Walker JA, Kump DK, Samuels AK, Monaghan JR, Weisrock DW, Staben C, Voss SR. 2005. Salsite: integrating new and existing ambystomatid salamander research and informational resources. BMC Genomics 6
48. Sousa S, Afonso N, Bensimon-Brito A, Fonseca M, Simoes M, Leon J, Roehl H, Cancela ML, Jacinto A. 2011. Differentiated skeletal cells contribute to blastema formation during zebrafish fin regeneration. Development 138:3897–3905. doi: 10.1242/dev.064717
49. Stachura DL, Reyes JR, Bartunek P, Paw BH, Zon LI, Traver D. 2009. Zebrafish kidney stromal cell lines support multilineage hematopoiesis. Blood 114:279–289. doi: 10.1182/blood-2009-02-203638
50. Straube WL, Tanaka EM. 2006. Reversibility of the differentiated state: regeneration in amphibians. Artificial Organs 30:743–755. doi: 10.1111/j.1525-1594.2006.00296.x
51. Tu S, Johnson SL. 2011. Fate restriction in the growing and regenerating zebrafish fin. Developmental Cell 20: 725–732. doi: 10.1016/j.devcel.2011.04.013
52. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA. 2004. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (New York, N.Y.) 303:844–848. doi: 10.1126/science.1092472
53. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. 2000. P53-independent functions of the p19(ARF) tumor suppressor. Genes & Development 14:2358–2365. doi: 10.1101/gad.827300
54. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. 1999. Nucleolar arf sequesters Mdm2 and activates p53. Nature Cell Biology 1:20–26. doi: 10.1038/8991
55. Wehner D, Cizelsky W, Vasudevaro MD, Ozhan Günes, Haase C, Kagermeier-Schenk B, Röder A, Dorsky RI, Moro E, Argenton F, Kühl M, Weidinger G. 2014. Wnt-catenin signaling defines organizing centers that orchestrate growth and differentiation of the regenerating zebrafish caudal finn. Cell Reports 6:467–481. doi: 10.1016/j.celrep.2013.12.036
56. Wells J, Graveel CR, Bartley SM, Madore SJ, Farnham PJ. 2002. The identification of E2F1-specific target genes. Proceedings of the National Academy of Sciences of the United States of America 99:3890–3895. doi: 10.1073/pnas.062047499
57. Wills AA, Kidd AR, Lepilina A, Poss KD. 2008. Fgfs control homeostatic regeneration in adult zebrafish fins. Development (Cambridge, England) 135:3063–3070. doi: 10.1242/dev.024588
58. Yadav VK, Kumar A, Mann A, Aggarwal S, Kumar M, Roy SD, Pore SK, Banerjee R, Mahesh Kumar J, Thakur RK, Chowdhury S. 2014. Engineered reversal of drug resistance in cancer cells–metastases suppressor factors as change agents. Nucleic Acids Research 42:764–773. doi: 10.1093/nar/gkt946
59. Yun MH, Gates PB, Brockes JP. 2013. Regulation of p53 is critical for vertebrate limb regeneration. Proceedings of the National Academy of Sciences of the United States of America 110:17392–17397. doi: 10.1073/pnas.1310519110
60. Zindy F, Williams RT, Baudino TA, Rehg JE, Skapek SX, Cleveland JL, Roussel MF, Sherr CJ. 2003. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proceedings of the National Academy of Sciences of the United States of America 100:15930–15935. doi: 10.1073/pnas.2536808100